| Schedule of Calculation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders |
The following table presents the calculation of basic and diluted net income (loss) per share attributable to common stockholders for the three and six months ended June 30, 2025 and 2024: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Numerator: | | | | | | | | | Net income (loss) | $ | (74,724) | | | $ | (37,322) | | | $ | 55,208 | | | $ | (70,331) | | | Earnings attributable to participating Class A Common Shares held in escrow in connection with Amelia acquisition | — | | | — | | | (297) | | | — | | | Cumulative dividends attributable to Series A Preferred Stock | — | | | (73) | | | — | | | (416) | | | Net income (loss) attributable to common shareholders - basic | $ | (74,724) | | | $ | (37,395) | | | $ | 54,911 | | | $ | (70,747) | | | | | | | | | | | Net income (loss) | (74,724) | | | (37,322) | | | 55,208 | | | (70,331) | | | Change in fair value of dilutive instruments classified as derivatives | (602) | | | — | | | (1,503) | | | — | | | Cumulative dividends attributable to Series A Preferred Stock | $ | — | | | $ | (73) | | | $ | — | | | $ | (416) | | | Net income (loss) attributable to common shareholders - diluted | $ | (75,326) | | | $ | (37,395) | | | $ | 53,705 | | | $ | (70,747) | | | | | | | | | | | Denominator: | | | | | | | | | Weighted average shares outstanding – basic | 400,124,499 | | 331,830,608 | | 397,026,119 | | 309,213,583 | | Effect of potentially dilutive equivalent shares | 1,918,969 | | 0 | | 17,119,758 | | 0 | | Weighted average shares outstanding – diluted | 402,043,468 | | 331,830,608 | | 414,145,877 | | 309,213,583 | | | | | | | | | | Basic net income (loss) per share | $ | (0.19) | | | $ | (0.11) | | | $ | 0.14 | | | $ | (0.23) | | | Diluted net income (loss) per share | $ | (0.19) | | | $ | (0.11) | | | $ | 0.13 | | | $ | (0.23) | |
|
| Schedule of Outstanding Shares of Potentially Dilutive Securities |
| | | | | | | | | | | | | As of June 30, | | 2025 | | 2024 | | Stock-based awards | 12,477,419 | | 28,919,026 | | Series A Preferred Stock | — | | — | | Common stock warrants | — | | 3,665,996 | | Unvested restricted stock awards | 280,953 | | 2,033,156 | | Contingently issuable shares | 10,385 | | 1,906,746 | | Total | 12,768,757 | | 36,524,924 |
|